These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9218725)

  • 21. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Evolution of Tumors in Mice and Humans with Germline p53 Mutations.
    Levine AJ; Chan CS; Dudgeon C; Puzio-Kuter A; Hainaut P
    Cold Spring Harb Symp Quant Biol; 2015; 80():139-45. PubMed ID: 26642854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature.
    Baek YS; Seo JY; Song JY; Lee SY; Kim A; Jeon J
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e174-e175. PubMed ID: 30653764
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Bougeard G; Limacher JM; Martin C; Charbonnier F; Killian A; Delattre O; Longy M; Jonveaux P; Fricker JP; Stoppa-Lyonnet D; Flaman JM; Frébourg T
    J Med Genet; 2001 Apr; 38(4):253-7. PubMed ID: 11370630
    [No Abstract]   [Full Text] [Related]  

  • 25. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
    Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing.
    Schwarzbraun T; Obenauf AC; Langmann A; Gruber-Sedlmayr U; Wagner K; Speicher MR; Kroisel PM
    J Med Genet; 2009 May; 46(5):341-4. PubMed ID: 19269943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CANCER. The cancer predisposition revolution.
    Malkin D; Garber JE; Strong LC; Friend SH
    Science; 2016 May; 352(6289):1052-3. PubMed ID: 27230363
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.
    Chao MM; Levine JE; Ruiz RE; Kohlmann WK; Bower MA; Petty EM; Mody RJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):1000-4. PubMed ID: 16333835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging.
    Ballinger ML; Ferris NJ; Moodie K; Mitchell G; Shanley S; James PA; Thomas DM
    JAMA Oncol; 2017 Dec; 3(12):1735-1736. PubMed ID: 28772290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased sperm aneuploidy in two male carriers of germline TP53 mutations.
    Paulasova P; Diblik J; Trkova M; Macek M; Sedlacek Z
    Cancer Genet; 2011 May; 204(5):278-81. PubMed ID: 21665182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.
    Palmero EI; Achatz MI; Ashton-Prolla P; Olivier M; Hainaut P
    Curr Opin Oncol; 2010 Jan; 22(1):64-9. PubMed ID: 19952748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.
    Andrade RC; de Lima MAFD; de Faria PAS; Vargas FR
    Fam Cancer; 2018 Jan; 17(1):119-122. PubMed ID: 28477317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.
    Ricordel C; Labalette-Tiercin M; Lespagnol A; Kerjouan M; Dugast C; Mosser J; Desrues B; Léna H
    Lung Cancer; 2015 Jan; 87(1):80-4. PubMed ID: 25433984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and functional analysis of a Li Fraumeni syndrome family in China.
    Hu H; Liu J; Liao X; Zhang S; Li H; Lu R; Li X; Lin W; Liu M; Xia Z; Qing G; Li JD
    Sci Rep; 2016 Jan; 6():20221. PubMed ID: 26818906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cancer-predisposing variants in one family: Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li-Fraumeni syndrome.
    Pahl L; Beier R; von Neuhoff N; Auber B; Höfs M; Prott EC; Schlegelberger B; Reinhardt D; Steinemann D
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27254. PubMed ID: 29893455
    [No Abstract]   [Full Text] [Related]  

  • 38. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer surveillance for individuals with Li-Fraumeni syndrome.
    Kratz CP; Villani A; Nichols KE; Schiffman J; Malkin D
    Eur J Hum Genet; 2020 Nov; 28(11):1481-1482. PubMed ID: 32814850
    [No Abstract]   [Full Text] [Related]  

  • 40. Orbital sarcoma in a young patient with Li-Fraumeni syndrome.
    Salam T; Salvi SM; Thaung C; Rose GE
    Arch Ophthalmol; 2012 May; 130(5):662-4. PubMed ID: 22652861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.